These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues. Gauthier S; Leuzy A; Racine E; Rosa-Neto P Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568 [TBL] [Abstract][Full Text] [Related]
43. [Early detection of Alzheimer's disease and dementia prediction in patients with mild cognitive impairment : Summary of current recommendations]. Rostamzadeh A; Jessen F Nervenarzt; 2020 Sep; 91(9):832-842. PubMed ID: 32300816 [TBL] [Abstract][Full Text] [Related]
44. Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology. Osborn KE; Alverio JM; Dumitrescu L; Pechman KR; ; Gifford KA; Hohman TJ; Blennow K; Zetterberg H; Jefferson AL J Alzheimers Dis; 2019; 71(1):281-290. PubMed ID: 31381510 [TBL] [Abstract][Full Text] [Related]
45. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Blennow K; Dubois B; Fagan AM; Lewczuk P; de Leon MJ; Hampel H Alzheimers Dement; 2015 Jan; 11(1):58-69. PubMed ID: 24795085 [TBL] [Abstract][Full Text] [Related]
46. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624 [TBL] [Abstract][Full Text] [Related]
47. Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes. Schweda M; Kögel A; Bartels C; Wiltfang J; Schneider A; Schicktanz S J Alzheimers Dis; 2018; 62(1):145-155. PubMed ID: 29439325 [TBL] [Abstract][Full Text] [Related]
48. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota. Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623 [TBL] [Abstract][Full Text] [Related]
49. A clinical index to predict progression from mild cognitive impairment to dementia due to Alzheimer's disease. Lee SJ; Ritchie CS; Yaffe K; Stijacic Cenzer I; Barnes DE PLoS One; 2014; 9(12):e113535. PubMed ID: 25486250 [TBL] [Abstract][Full Text] [Related]
50. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia. Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536 [TBL] [Abstract][Full Text] [Related]
51. Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection. Risacher SL; Saykin AJ Annu Rev Clin Psychol; 2013; 9():621-48. PubMed ID: 23297785 [TBL] [Abstract][Full Text] [Related]
52. Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer's disease. Kulic L; Unschuld PG Curr Opin Neurol; 2016 Dec; 29(6):749-755. PubMed ID: 27805971 [TBL] [Abstract][Full Text] [Related]